Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study

Multidrug-resistant tuberculosis had high treatment failure and mortality. Success rate of treatment currently 56% at global level, 48% in Indonesia and 36% in West Java province, the most populated province and surround Jakarta, the capitol of Indonesia. This study aimed to evaluate factors affecti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2021-02, Vol.16 (2), p.e0246284-e0246284
Hauptverfasser: Soeroto, Arto Yuwono, Pratiwi, Chica, Santoso, Prayudi, Lestari, Bony Wiem
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0246284
container_issue 2
container_start_page e0246284
container_title PloS one
container_volume 16
creator Soeroto, Arto Yuwono
Pratiwi, Chica
Santoso, Prayudi
Lestari, Bony Wiem
description Multidrug-resistant tuberculosis had high treatment failure and mortality. Success rate of treatment currently 56% at global level, 48% in Indonesia and 36% in West Java province, the most populated province and surround Jakarta, the capitol of Indonesia. This study aimed to evaluate factors affecting success of multidrug-resistant tuberculosis treatment in patients using longer treatment regimen in West Java Indonesia. This was a retrospective cohort study of multidrug-resistant tuberculosis patients treated with longer regimen at Hasan Sadikin General Hospital from January 2015 to December 2017. Potential risk factors associated with the treatment outcome were analyzed using multiple logistic regression. A total of 492 patients were enrolled during the study period. Fifty percents multidrug-resistant tuberculosis patients had successful treatment outcome. Age ≤45 years, male, normal body mass index, no previous tuberculosis treatment, culture conversion ≤2 months, acid fast bacilli sputum smear ≤+1 were independent factors associated with increased treatment success. Sputum culture conversion ≤2 months was the major factor affecting successful outcome (RR 2.79; 95% CI: 1.61-4.84; p-value
doi_str_mv 10.1371/journal.pone.0246284
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2487424953</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A651160957</galeid><doaj_id>oai_doaj_org_article_27c54967b9e4448293d1f70e7a40aaa6</doaj_id><sourcerecordid>A651160957</sourcerecordid><originalsourceid>FETCH-LOGICAL-c743t-c8a2cfdac9dfc670378e177bffba36f1dc617b160bee9b0ed96f0b7017814a913</originalsourceid><addsrcrecordid>eNqNk89u1DAQxiMEoqXwBggsISE47GInjp1wQKoqCosqVeLv0Zo446xXSbzYTkWfgZfGy26rXdQDyiHR-DffzHzOZNlTRueskOzNyk1-hH6-diPOac5FXvF72TGri3wmclrc3_s-yh6FsKK0LCohHmZHRVGWgtb8OPt9Djo6HwgYgzrasSNuitoNSJwhvRs79MRjZwccyTD10bZ-6mYegw0Rxkji1KDXU-9SgESPEBMZiR3JDwyRfIIrIIuxTU0GC2_JaRKL3oX1ptgVEu2WzkcS4tReP84eGOgDPtm9T7Jv5--_nn2cXVx-WJydXsy05EWc6QpybVrQdWu0kLSQFTIpG2MaKIRhrRZMNkzQBrFuKLa1MLSRlMmKcahZcZI93-quU9dq52NQOa8kz3ldFolYbInWwUqtvR3AXysHVv0NON8p8NHqHlUudclrIZsaOedVXhctM5KiBE4BQCStd7tqUzNgq5M7HvoD0cOT0S5V566UrCSlFU0Cr3YC3v2ckqlqsEFj38OIbtr2LbmUbDPZi3_Qu6fbUR2kAexoXKqrN6LqVJQsOVeXMlHzO6j0tDhYne7T2BQ_SHh9kJCYiL9iB1MIavHl8_-zl98P2Zd77BKhj8vg-ilaN4ZDkG9BnX6w4NHcmsyo2uzMjRtqszNqtzMp7dn-Bd0m3SxJ8QckWRTo</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2487424953</pqid></control><display><type>article</type><title>Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Public Library of Science (PLoS)</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Soeroto, Arto Yuwono ; Pratiwi, Chica ; Santoso, Prayudi ; Lestari, Bony Wiem</creator><contributor>Marotta, Claudia</contributor><creatorcontrib>Soeroto, Arto Yuwono ; Pratiwi, Chica ; Santoso, Prayudi ; Lestari, Bony Wiem ; Marotta, Claudia</creatorcontrib><description>Multidrug-resistant tuberculosis had high treatment failure and mortality. Success rate of treatment currently 56% at global level, 48% in Indonesia and 36% in West Java province, the most populated province and surround Jakarta, the capitol of Indonesia. This study aimed to evaluate factors affecting success of multidrug-resistant tuberculosis treatment in patients using longer treatment regimen in West Java Indonesia. This was a retrospective cohort study of multidrug-resistant tuberculosis patients treated with longer regimen at Hasan Sadikin General Hospital from January 2015 to December 2017. Potential risk factors associated with the treatment outcome were analyzed using multiple logistic regression. A total of 492 patients were enrolled during the study period. Fifty percents multidrug-resistant tuberculosis patients had successful treatment outcome. Age ≤45 years, male, normal body mass index, no previous tuberculosis treatment, culture conversion ≤2 months, acid fast bacilli sputum smear ≤+1 were independent factors associated with increased treatment success. Sputum culture conversion ≤2 months was the major factor affecting successful outcome (RR 2.79; 95% CI: 1.61-4.84; p-value&lt;0.001). Human Immunodeficiency Virus infection, chronic kidney disease, and cavitary lesion were independent risk factors for unfavourable outcome. Age, gender, body mass index, tuberculosis treatment history, time of sputum conversion, acid fast bacilli sputum smear, HIV infection, chronic kidney disease, and cavitary lesion can be used as predictors for longer multidrug-resistant tuberculosis treatment regimen outcome.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0246284</identifier><identifier>PMID: 33556094</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Anemia ; Bacilli ; Biology and Life Sciences ; Body mass ; Body mass index ; Body size ; Body weight loss ; Care and treatment ; Clinical outcomes ; Cohort analysis ; Critical care ; Diabetes ; Diabetes mellitus ; Diagnosis ; Drug resistance ; Editing ; Ethambutol ; Health risks ; HIV ; Hospitals ; Human immunodeficiency virus ; Internal medicine ; Isoniazid ; Kidney diseases ; Low income groups ; Medical treatment ; Medicine ; Medicine and Health Sciences ; Multidrug resistance ; Multidrug resistant organisms ; Multivariate analysis ; Patients ; Prognosis ; Public health ; Research facilities ; Reviews ; Rifampin ; Sexually transmitted diseases ; Sputum ; Statistical analysis ; STD ; Streptomycin ; Success ; Thorax ; Tuberculosis ; Viruses ; Weight loss</subject><ispartof>PloS one, 2021-02, Vol.16 (2), p.e0246284-e0246284</ispartof><rights>COPYRIGHT 2021 Public Library of Science</rights><rights>2021 Soeroto et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Soeroto et al 2021 Soeroto et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c743t-c8a2cfdac9dfc670378e177bffba36f1dc617b160bee9b0ed96f0b7017814a913</citedby><cites>FETCH-LOGICAL-c743t-c8a2cfdac9dfc670378e177bffba36f1dc617b160bee9b0ed96f0b7017814a913</cites><orcidid>0000-0001-9027-2453 ; 0000-0002-3623-0954</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870080/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870080/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,862,883,2098,2917,23853,27911,27912,53778,53780,79355,79356</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33556094$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Marotta, Claudia</contributor><creatorcontrib>Soeroto, Arto Yuwono</creatorcontrib><creatorcontrib>Pratiwi, Chica</creatorcontrib><creatorcontrib>Santoso, Prayudi</creatorcontrib><creatorcontrib>Lestari, Bony Wiem</creatorcontrib><title>Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Multidrug-resistant tuberculosis had high treatment failure and mortality. Success rate of treatment currently 56% at global level, 48% in Indonesia and 36% in West Java province, the most populated province and surround Jakarta, the capitol of Indonesia. This study aimed to evaluate factors affecting success of multidrug-resistant tuberculosis treatment in patients using longer treatment regimen in West Java Indonesia. This was a retrospective cohort study of multidrug-resistant tuberculosis patients treated with longer regimen at Hasan Sadikin General Hospital from January 2015 to December 2017. Potential risk factors associated with the treatment outcome were analyzed using multiple logistic regression. A total of 492 patients were enrolled during the study period. Fifty percents multidrug-resistant tuberculosis patients had successful treatment outcome. Age ≤45 years, male, normal body mass index, no previous tuberculosis treatment, culture conversion ≤2 months, acid fast bacilli sputum smear ≤+1 were independent factors associated with increased treatment success. Sputum culture conversion ≤2 months was the major factor affecting successful outcome (RR 2.79; 95% CI: 1.61-4.84; p-value&lt;0.001). Human Immunodeficiency Virus infection, chronic kidney disease, and cavitary lesion were independent risk factors for unfavourable outcome. Age, gender, body mass index, tuberculosis treatment history, time of sputum conversion, acid fast bacilli sputum smear, HIV infection, chronic kidney disease, and cavitary lesion can be used as predictors for longer multidrug-resistant tuberculosis treatment regimen outcome.</description><subject>Anemia</subject><subject>Bacilli</subject><subject>Biology and Life Sciences</subject><subject>Body mass</subject><subject>Body mass index</subject><subject>Body size</subject><subject>Body weight loss</subject><subject>Care and treatment</subject><subject>Clinical outcomes</subject><subject>Cohort analysis</subject><subject>Critical care</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diagnosis</subject><subject>Drug resistance</subject><subject>Editing</subject><subject>Ethambutol</subject><subject>Health risks</subject><subject>HIV</subject><subject>Hospitals</subject><subject>Human immunodeficiency virus</subject><subject>Internal medicine</subject><subject>Isoniazid</subject><subject>Kidney diseases</subject><subject>Low income groups</subject><subject>Medical treatment</subject><subject>Medicine</subject><subject>Medicine and Health Sciences</subject><subject>Multidrug resistance</subject><subject>Multidrug resistant organisms</subject><subject>Multivariate analysis</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Public health</subject><subject>Research facilities</subject><subject>Reviews</subject><subject>Rifampin</subject><subject>Sexually transmitted diseases</subject><subject>Sputum</subject><subject>Statistical analysis</subject><subject>STD</subject><subject>Streptomycin</subject><subject>Success</subject><subject>Thorax</subject><subject>Tuberculosis</subject><subject>Viruses</subject><subject>Weight loss</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk89u1DAQxiMEoqXwBggsISE47GInjp1wQKoqCosqVeLv0Zo446xXSbzYTkWfgZfGy26rXdQDyiHR-DffzHzOZNlTRueskOzNyk1-hH6-diPOac5FXvF72TGri3wmclrc3_s-yh6FsKK0LCohHmZHRVGWgtb8OPt9Djo6HwgYgzrasSNuitoNSJwhvRs79MRjZwccyTD10bZ-6mYegw0Rxkji1KDXU-9SgESPEBMZiR3JDwyRfIIrIIuxTU0GC2_JaRKL3oX1ptgVEu2WzkcS4tReP84eGOgDPtm9T7Jv5--_nn2cXVx-WJydXsy05EWc6QpybVrQdWu0kLSQFTIpG2MaKIRhrRZMNkzQBrFuKLa1MLSRlMmKcahZcZI93-quU9dq52NQOa8kz3ldFolYbInWwUqtvR3AXysHVv0NON8p8NHqHlUudclrIZsaOedVXhctM5KiBE4BQCStd7tqUzNgq5M7HvoD0cOT0S5V566UrCSlFU0Cr3YC3v2ckqlqsEFj38OIbtr2LbmUbDPZi3_Qu6fbUR2kAexoXKqrN6LqVJQsOVeXMlHzO6j0tDhYne7T2BQ_SHh9kJCYiL9iB1MIavHl8_-zl98P2Zd77BKhj8vg-ilaN4ZDkG9BnX6w4NHcmsyo2uzMjRtqszNqtzMp7dn-Bd0m3SxJ8QckWRTo</recordid><startdate>20210208</startdate><enddate>20210208</enddate><creator>Soeroto, Arto Yuwono</creator><creator>Pratiwi, Chica</creator><creator>Santoso, Prayudi</creator><creator>Lestari, Bony Wiem</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9027-2453</orcidid><orcidid>https://orcid.org/0000-0002-3623-0954</orcidid></search><sort><creationdate>20210208</creationdate><title>Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study</title><author>Soeroto, Arto Yuwono ; Pratiwi, Chica ; Santoso, Prayudi ; Lestari, Bony Wiem</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c743t-c8a2cfdac9dfc670378e177bffba36f1dc617b160bee9b0ed96f0b7017814a913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Anemia</topic><topic>Bacilli</topic><topic>Biology and Life Sciences</topic><topic>Body mass</topic><topic>Body mass index</topic><topic>Body size</topic><topic>Body weight loss</topic><topic>Care and treatment</topic><topic>Clinical outcomes</topic><topic>Cohort analysis</topic><topic>Critical care</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diagnosis</topic><topic>Drug resistance</topic><topic>Editing</topic><topic>Ethambutol</topic><topic>Health risks</topic><topic>HIV</topic><topic>Hospitals</topic><topic>Human immunodeficiency virus</topic><topic>Internal medicine</topic><topic>Isoniazid</topic><topic>Kidney diseases</topic><topic>Low income groups</topic><topic>Medical treatment</topic><topic>Medicine</topic><topic>Medicine and Health Sciences</topic><topic>Multidrug resistance</topic><topic>Multidrug resistant organisms</topic><topic>Multivariate analysis</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Public health</topic><topic>Research facilities</topic><topic>Reviews</topic><topic>Rifampin</topic><topic>Sexually transmitted diseases</topic><topic>Sputum</topic><topic>Statistical analysis</topic><topic>STD</topic><topic>Streptomycin</topic><topic>Success</topic><topic>Thorax</topic><topic>Tuberculosis</topic><topic>Viruses</topic><topic>Weight loss</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Soeroto, Arto Yuwono</creatorcontrib><creatorcontrib>Pratiwi, Chica</creatorcontrib><creatorcontrib>Santoso, Prayudi</creatorcontrib><creatorcontrib>Lestari, Bony Wiem</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Soeroto, Arto Yuwono</au><au>Pratiwi, Chica</au><au>Santoso, Prayudi</au><au>Lestari, Bony Wiem</au><au>Marotta, Claudia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2021-02-08</date><risdate>2021</risdate><volume>16</volume><issue>2</issue><spage>e0246284</spage><epage>e0246284</epage><pages>e0246284-e0246284</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Multidrug-resistant tuberculosis had high treatment failure and mortality. Success rate of treatment currently 56% at global level, 48% in Indonesia and 36% in West Java province, the most populated province and surround Jakarta, the capitol of Indonesia. This study aimed to evaluate factors affecting success of multidrug-resistant tuberculosis treatment in patients using longer treatment regimen in West Java Indonesia. This was a retrospective cohort study of multidrug-resistant tuberculosis patients treated with longer regimen at Hasan Sadikin General Hospital from January 2015 to December 2017. Potential risk factors associated with the treatment outcome were analyzed using multiple logistic regression. A total of 492 patients were enrolled during the study period. Fifty percents multidrug-resistant tuberculosis patients had successful treatment outcome. Age ≤45 years, male, normal body mass index, no previous tuberculosis treatment, culture conversion ≤2 months, acid fast bacilli sputum smear ≤+1 were independent factors associated with increased treatment success. Sputum culture conversion ≤2 months was the major factor affecting successful outcome (RR 2.79; 95% CI: 1.61-4.84; p-value&lt;0.001). Human Immunodeficiency Virus infection, chronic kidney disease, and cavitary lesion were independent risk factors for unfavourable outcome. Age, gender, body mass index, tuberculosis treatment history, time of sputum conversion, acid fast bacilli sputum smear, HIV infection, chronic kidney disease, and cavitary lesion can be used as predictors for longer multidrug-resistant tuberculosis treatment regimen outcome.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>33556094</pmid><doi>10.1371/journal.pone.0246284</doi><tpages>e0246284</tpages><orcidid>https://orcid.org/0000-0001-9027-2453</orcidid><orcidid>https://orcid.org/0000-0002-3623-0954</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2021-02, Vol.16 (2), p.e0246284-e0246284
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2487424953
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Public Library of Science (PLoS); PubMed Central; Free Full-Text Journals in Chemistry
subjects Anemia
Bacilli
Biology and Life Sciences
Body mass
Body mass index
Body size
Body weight loss
Care and treatment
Clinical outcomes
Cohort analysis
Critical care
Diabetes
Diabetes mellitus
Diagnosis
Drug resistance
Editing
Ethambutol
Health risks
HIV
Hospitals
Human immunodeficiency virus
Internal medicine
Isoniazid
Kidney diseases
Low income groups
Medical treatment
Medicine
Medicine and Health Sciences
Multidrug resistance
Multidrug resistant organisms
Multivariate analysis
Patients
Prognosis
Public health
Research facilities
Reviews
Rifampin
Sexually transmitted diseases
Sputum
Statistical analysis
STD
Streptomycin
Success
Thorax
Tuberculosis
Viruses
Weight loss
title Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T20%3A40%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20affecting%20outcome%20of%20longer%20regimen%20multidrug-resistant%20tuberculosis%20treatment%20in%20West%20Java%20Indonesia:%20A%20retrospective%20cohort%20study&rft.jtitle=PloS%20one&rft.au=Soeroto,%20Arto%20Yuwono&rft.date=2021-02-08&rft.volume=16&rft.issue=2&rft.spage=e0246284&rft.epage=e0246284&rft.pages=e0246284-e0246284&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0246284&rft_dat=%3Cgale_plos_%3EA651160957%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2487424953&rft_id=info:pmid/33556094&rft_galeid=A651160957&rft_doaj_id=oai_doaj_org_article_27c54967b9e4448293d1f70e7a40aaa6&rfr_iscdi=true